Timothy M Illidge (Tim M Illidge, Timothy Illidge, T M Illidge, Tim Illidge)

Scopus Author ID ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Topics

Radiation Therapy

Diffuse Large B Cell Lymphoma

Squamous Cell Carcinoma

Hodgkin Lymphoma

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

EMBO molecular medicine

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Vicky Smith, Dave Lee, Mark Reardon, Rekaya Shabbir, Sudhakar Sahoo, Peter J Hoskin, Ananya Choudhury, Timothy M Illidge, Catharine M L West
Hypoxia Is Associated with Increased Immune Infiltrates and Both Anti-Tumour and Immune Suppressive Signalling in Muscle-Invasive Bladder Cancer. International journal of molecular sciences 24 (10) (2023)
Chalid Assaf, Timothy M Illidge, Nathalie Waser, Mary He, Tina Li, Athanasios Zomas, Nawal Bent-Ennakhil, Meredith Little, Pablo L Ortiz-Romero, Nicola Pimpinelli, Mehul Dalal, Martine Bagot
A Retrospective Chart Review of Treatment Patterns and Overall Survival among a Cohort of Patients with Relapsed/Refractory Mycosis Fungoides in France, Germany, Italy, Spain and the United Kingdom. Cancers 15 (23) (2023)
Vicky Smith, Debayan Mukherjee, Anna Maria Tsakiroglou, Alexander R Baker, Hitesh Mistry, Ananya Choudhury, Peter J Hoskin, Timothy M Illidge, Catharine M L West
Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer. Cancers 15 (1) (2022)
James M Price, Hitesh B Mistry, Guy Betts, Eleanor J Cheadle, Lynne Dixon, Kate Garcez, Timothy M Illidge, Zsuzsanna Iyizoba-Ebozue, Lip Wai Lee, Andrew McPartlin, Robin J D Prestwich, Savvas Papageorgiou, Dylan J Pritchard, Andrew Sykes, Catharine M L West, David J Thomson
Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (20) (2022)
Vicky Smith, Debayan Mukherjee, Anna Maria Tsakiroglou, Alexander R Baker, Hitesh Mistry, Ananya Choudhury, Peter J Hoskin, Timothy M Illidge, Catharine M L West
Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer. Cancers 15 (1) (2022)
Vicky Smith, Debayan Mukherjee, Anna Maria Tsakiroglou, Alexander R Baker, Hitesh Mistry, Ananya Choudhury, Peter J Hoskin, Timothy M Illidge, Catharine M L West
Low CD8 T Cell Counts Predict Benefit from Hypoxia-Modifying Therapy in Muscle-Invasive Bladder Cancer. Cancers 15 (1) (2022)
Erminia Romano, Jamie Honeychurch, Timothy M Illidge
Radiotherapy-Immunotherapy Combination: How Will We Bridge the Gap Between Pre-Clinical Promise and Effective Clinical Delivery? Cancers 13 (3) (2021)
David J Cutter, Johanna Ramroth, Patricia Diez, Andy Buckle, Georgios Ntentas, Bilyana Popova, Laura Clifton-Hadley, Peter J Hoskin, Sarah C Darby, John Radford, Timothy M Illidge
Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (32) (2021)
Chalid Assaf, Nathalie Waser, Martine Bagot, Mary He, Tina Li, Mehul Dalal, Francois Gavini, Fabrizio Trinchese, Athanasios Zomas, Meredith Little, Nicola Pimpinelli, Pablo L Ortiz-Romero, Timothy M Illidge
Contemporary Treatment Patterns and Response in Relapsed/Refractory Cutaneous T-Cell Lymphoma (CTCL) across Five European Countries. Cancers 14 (1) (2021)
Urszula M Cytlak, Douglas P Dyer, Jamie Honeychurch, Kaye J Williams, Mark A Travis, Timothy M Illidge
Immunomodulation by radiotherapy in tumour control and normal tissue toxicity. Nature reviews. Immunology (2021)
Madyson Colton, Eleanor J Cheadle, Jamie Honeychurch, Timothy M Illidge
Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations. Radiation oncology (London, England) 15 (1) (2020)
Elizabeth H Phillips, Timothy M Illidge
Is it time to rethink checkpoint blockade therapy in non-Hodgkin lymphoma? British journal of haematology 191 (1) (2020)
D Gilson, Sean Whittaker, F J Child, Julia J Scarisbrick, Timothy M Illidge, E J Parry, M F Mohd Mustapa, L S Exton, E Kanfer, K Rezvani, C E Dearden, S L Morris
British Association of Dermatologists and U.K. Cutaneous Lymphoma Group guidelines for the management of primary cutaneous lymphomas 2018. The British journal of dermatology 180 (3) (2018)
Emma J Searle, Brian A Telfer, Debayan Mukherjee, Duncan M Forster, Barry R Davies, Kaye J Williams, Ian J Stratford, Timothy M Illidge
Akt inhibition improves long-term tumour control following radiotherapy by altering the microenvironment. EMBO molecular medicine 9 (12) (2018)